Mast cell-derived VEGF enhances the passage of IgE FE-3 through the rat aortic endothelial cell monolayer

International Archives of Allergy and Immunology

Volumn 129, Issue 1, 2002, Pages 76-85

  Nakasone, Toshiyuki ^a   Hanashiro, Kazuhiko ^a   Nakamura, Mariko ^a   Sunakawa, Hajime ^a   Kosugi, Tadayoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Endothelial cell; IgE; IgE mediated inflammation; Mast cell; Mast cell derived VEGF; Permeability

Indexed keywords

CIMETIDINE; DIPHENHYDRAMINE; IMMUNOGLOBULIN E; SURAMIN; TRANEXAMIC ACID; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CONTROLLED STUDY; DRUG CONCENTRATION; ENDOTHELIUM CELL; EXPLANT; EXTRAVASCULAR SPACE; IN VITRO STUDY; MAST CELL; NONHUMAN; PERITONEAL CAVITY; PERMEABILITY; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RAT STRAIN;

ANIMALS; AORTA; BLOTTING, WESTERN; CALCIMYCIN; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; IMMUNOGLOBULIN E; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MAST CELLS; PERMEABILITY; RATS; RATS, WISTAR; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036423879     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065176     Document Type: Article

References (30)

1. Saitoh S, Tamaki N, Kosugi T: The relationship between specific IgE antibodies detected by mast system and total IgE in allergic rhinitis (in Japanese). Otologia (Fukuoka) 1992;38:752-756.
2. Iio A, Waldmann TA, Strober W: Metabolic study of human IgE: Evidence for an extravascular catabolic pathway. J Immunol 1978;120:1696-1701.
3. Hanashiro K, Nakamura M, Nakasone T, Tokeshi Y, Kosugi T: Permeability of rat IgE across rat aortic endothelial cell is enhanced by histamine. Allergol Int 2001;50:223-230.
4. Senger DR, Connolly DT, van de Water L, Feder J, Dvorak HF: Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990;50:1774-1778.
5. Boesinger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ: Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J Exp Med 1998;188:1135-1145.
6. Hanashiro K, Nakamura N, Tamaki T, Kosugi T: Production of monoclonal dinitrophenyl-specific rat IgE and establishment of an IgE capture ELISA for estimating the concentration of rat IgE antibodies to dinitrophenyl-Ascaris suum.Int Arch Allergy Immunol 1996;110:371-397.
7. Axen R, Porath J, Ernback S: Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 1967;214:1302-1304.
8. Nakasone T, Hanashiro K, Nakamura M, Sunakawa H, Kosugi T: An improved method for the detection of IgE FE-3 by ELISA using monoclonal anti-IgE FE-3 antibody. Ryukyu Med J 2001;20:129-135.
9. Strejan G, Campbell DH: Hypersensitivity to Ascaris antigens. I. Skin-sensitizing activity of serum fractions from guinea pigs sensitized to crude extracts. J Immunol 1967;98:893-900.
10. Eisen HN, Belman S, Carsten ME: The reaction of 2,4-dinitrobenzenesulfonic acid with free amino groups of proteins. J Am Chem Soc 1953;75:4583-4585.
11. Nerurkar LS, Jacob AJ, Madden DL, Sever JL: Detection of genital herpes simplex infections by a tissue culture-fluorescent-antibody technique with biotin-avidin. J Clin Microbiol 1983;17:149-154.
12. McGuire PG, Orkin RW: Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrata. Lab Invest 1987;57:94-105.
13. Pitas RE, Boyles, J, Mahiley RW, Bissell DM: Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells. J Cell Biol 1985;100:103-117.
14. Hayashi H, Ichikawa A, Saito T, Tomita K: Inhibitory role of cyclic adenosine 3′5′-monophosphate in histamine release from rat peritoneal mast cells in vitro. Biochem Pharmacol 1976;25:1907-1913.
15. Kuriu A, Sonoda S, Kanakura Y, Jozaki K, Yamatodani A, Kitamura Y: Proliferative potential of degranulated murine peritoneal mast cells. Blood 1989;74:925-929.
16. Heukeshoven J, Derinck R: Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985;6:103-112.
17. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
18. Engvall E, Perlmann P: Enzyme-linked immunosorbent assay. ELISA. III. Quantification of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972;109:129-135.
19. Cooper JA, Del Vecchio PJ, Minnear FL, Burhop KE, Selig WM, Malik AB: Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol 1987;62:1076-1083.
20. Sterk AR, Ishizaka T: Binding properties of IgE receptors on normal mouse mast cells. J Immunol 1982;128:838-843.
21. 2+ and purified isozymes in washed permeabilized cells. J Biol Chem 1993;268:1749-1756.
22. Sillaber C, Baghestanian M, Hofbauer R, Virgolini I, Bankl HC, Fureder W, Agis H, Willheim M, Leimer M, Scheiner O, Binder BR, Kiener HP, Bevec D, Fritsch G, Kress HG, Gadner H, Lechner K, Valent P: Molecular and functional characterization of the urokinase receptor on human mast cell. J Biol Chem 1997; 272:7824-7832.
23. Sillaber C, Baghestanian M, Bevec D, Willheim M, Agis H, Kapotis S, Fureder W, Bankl HC, Kiener HP, Speiser W, Binder BR, Lechner K, Valent P: The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J Immunol 1999;162:1032-1041.
24. Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986;46:5629-5632.
25. Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH: Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J Neurosurg 1989;71:884-891.
26. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR: Vascular permeability factor of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995;107:233-235.
27. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvery VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1982;219:983-985.
28. Yamaguchi M, Lantz CS, Ottegen HC, Katona M, Fleming T, Miyajima I, Kinet JP, Galli SJ: IgE enhances mouse mast cell FcεRI expression in vitro and in vivo. Evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997;185:663-672.
29. Yano K, Yamaguchi M, de Mora F, Lantz CS, Butterfield JH, Costa JJ, Galli SJ: Production of macrophage inflammatory protein-1 α by human mast cells: Increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest 1997;77:185-193.
30. Lum H, Malik AB: Regulation of vascular endothelial barrier function. Am J Physiol 1994;267:223-241.